Socio-economic aspects of neglected diseases: Sleeping sickness and visceral leishmaniasis

Annals of Tropical Medicine and Parasitology

Volumn 104, Issue 7, 2010, Pages 535-542

  Boelaert, M ^a   Meheus, F ^a   Robays, J ^a   Lutumba, P ^b,c  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF KINSHASA   (Congo)

^c National Institute of Biomedical Research   (Congo)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; MILTEFOSINE; PAROMOMYCIN; STIBOGLUCONATE SODIUM; SUNDAR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN TRYPANOSOMIASIS; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DRUG COST; ECONOMIC DEVELOPMENT; ENDEMIC DISEASE; EPIDEMIC; HEALTH CARE COST; HOME CARE; HOSPITAL CARE; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDUSTRIALIZATION; INFECTION CONTROL; MIXED INFECTION; POVERTY; REVIEW; SINGLE DRUG DOSE; SOCIOECONOMICS; VECTOR CONTROL; VISCERAL LEISHMANIASIS;

DEVELOPING COUNTRIES; HUMANS; LEISHMANIASIS, VISCERAL; NEGLECTED DISEASES; POVERTY; SOCIOECONOMIC FACTORS; TRYPANOSOMIASIS, AFRICAN;

EID: 78649273723     PISSN: 00034983     EISSN: 13648594     Source Type: Journal    
DOI: 10.1179/136485910X12786389891641     Document Type: Review

References (54)

1. Adhikari, S. R., Maskay, N. M & Sharma, B. P. (2009). Paying for hospital-based care of kala-azar in Nepal: assessing catastrophic, impoverishment and economic consequences. Health Policy and Planning, 24, 129-139.
2. Ali, A. & Ashford, R. W. (1994). Visceral leishmaniasis in Ethiopia. IV. Prevalence, incidence and relation of infection to disease in an endemic area. Annals of Tropical Medicine and Parasitology, 88, 289-293.
3. Alvar, J., Yactayo, S. & Bern, C. (2006). Leishmaniasis and poverty. Trends in Parasitology, 22, 552-557.
4. Boelaert, M., Meheus, F., Sanchez, A., Singh, S. P., Vanlerberghe, V., Picado, A., Meessen, B. & Sundar, S. (2009). The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Tropical Medicine and International Health, 14, 639-644.
5. Chappuis, F., Lima, M. A,. Flevaud, L. & Ritmeijer, K. (2010). Human African trypanosomiasis in areas without surveillance. Emerging Infectious Diseases, 16, 354-356.
6. Das, P., Samuels, S., Desjeux, P., Mittal, A., Topno, R., Siddiqui, N. A., Sur, D., Pandey, A. & Sarnoff, R. (2010). Annual incidence of visceral leishmaniasis in an endemic area of Bihar, India. Tropical Medicine and International Health, 15 (Suppl. 2), 4-11.
7. Desjeux, P. (1996). Leishmaniasis. Public health aspects and control. Clinics in Dermatology, 14, 417-423.
8. Dujardin, J. C., Campino, L., Canavate, M. C., Dedet, J. P., Gradoni, L., Soteriadou, K., Mazeris, A., Ozbel, Y. & Boelaert, M. (2008). Spread of vectorborne diseases and neglect of leishmaniasis, Europe. Emerging Infectious Diseases, 14, 1013-1018.
9. Gouteux, J. P. & Sinda, D. (1990). Community participation in the control of tsetse flies. Large scale trials using the pyramid trap in the Congo. Tropical Medicine and Parasitology, 41, 49-55.
10. Gouteux, J. P., Bansimba, P., Noireau, F. & Frezil, J. L. (1987). Le coût du traitement individuel de la trypanosomiase à T. b. gambiense dans le foyer du Niari (Congo). Médecine Tropicale, 47, 61-63.
11. Griekspoor, A., Sondorp, E. & Vos, T. (1999). Costeffectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan. Health Policy and Planning, 14, 70-76.
12. Hasker, E., Singh, S. P., Malaviya, P., Singh, R. P., Shankar, R., Boelaert, M. & Sundar, S. (2010). Management of visceral leishmaniasis in rural primary health care services in Bihar, India. Tropical Medicine and International Health, 15 (Suppl. 2), 55-62.
13. Holveck, J. C., Ehrenberg, J. P., Ault, S. K., Rojas, R., Vasquez, J., Cerqueira, M. T., Ippolito-Shepherd, J., Genovese, M. A. & Periago, M. R. (2007). Prevention, control, and elimination of neglected diseases in the Americas: pathways to integrated, inter-programmatic, inter-sectoral action for health and development. BMC Public Health, 7, 6.
14. Lancien, J. (1991). Lutte contre la maladie du sommeil dans le sud-est Ouganda par piégeage des glossines. Annales de la Société Belge de Médecine Tropicale, 71 (Suppl. 1), 35-47.
15. Laveissière, C. & Couret, D. (1986). La campagne pilote de lutte contre la trypanosomiase humaine dans le foyer de Vavoua (Côte d'Ivoire). 5. Bilan financier. Cahiers O. R. S. T. O. M., Série Entomologie Médicale et Parasitologie, 24, 149-153.
16. Lutumba, P., Robays, J., Miaka mia Bilenge, C., Betu Ku Mesu, V. K., Molisho, D., Declercq, J., van der Veken, W., Meheus, F., Jannin, J. & Boelaert, M. (2005). Trypanosomiasis control, Democratic Republic of Congo, 1993-2003. Emerging Infectious Diseases, 11, 1382-1388.
17. Lutumba, P., Makieya, E., Shaw, A., Meheus, F. & Boelaert, M. (2007). Human African trypanosomiasis in a rural community, Democratic Republic of Congo. Emerging Infectious Diseases, 13, 248-254.
18. Magnus, E., Vervoort, T. & van Meirvenne, N. (1978). A card-agglutination test with stained trypanosomes (CATT) for the serological diagnosis of Trypanosoma brucei gambiense trypanosomiasis. Annales de la Société Belge de Médecine Tropicale, 58, 169-176.
19. Marlet, M. V., Wuillaume, F., Jacquet, D., Quispe, K. W., Dujardin, J. C. & Boelaert, M. (2003) A neglected disease of humans: a new focus of visceral leishmaniasis in Bakool, Somalia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 667-671.
20. Meheus, F., Boelaert, M., Baltussen, R. & Sundar, S. (2006). Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India. Tropical Medicine and International Health, 11, 1715-1724.
21. Meheus, F., Balasegaram, M., Olliaro, P., Sundar, S., Rijal, S., Abul Faiz, M. & Boelaert, M. (2010). Costeffectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Neglected Tropical Diseases, in press.
22. Melaku, Y., Collin, S. M., Keus, K., Gatluak, F., Ritmeijer, K. & Davidson, R. N. (2007). Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy. American Journal of Tropical Medicine and Hygiene, 77, 89-94.
23. Moore, A., Richer, M., Enrile, M., Losio, E., Roberts, J. & Levy, D. (1999). Resurgence of sleeping sickness in Tambura county, Sudan. American Journal of Tropical Medicine and Hygiene, 61, 315-318.
24. Murray, C. J. L. & Lopez, A. D. (Eds) (1996). The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard School of Public Health.
25. Nightingale, S. L. (1991). Drug for sleeping sickness approved. Journal of the American Medical Association, 265, 1229.
26. Olliaro, P., Darley, S., Laxminarayan, R. & Sundar, S. (2009). Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India. Tropical Medicine and International Health, 14, 918-925.
27. Priotto, G., Kasparian, S., Mutombo, W., Ngouama, D., Ghorashian, S., Arnold, U., Ghabri, S., Baudin, E., Buard, V., Kazadi-Kyanza, S., Ilunga, M., Mutangala, W., Pohlig, G., Schmid, C., Karunakara, U., Torreele, E. & Kande, V. (2009). Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet, 374, 56-64.
28. Rijal, S., Chappuis, F., Singh, R., Bovier, P. A., Acharya, P., Karki, B. M., Das, M. L., Desjeux, P., Loutan, L. & Koirala, S. (2003). Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 350-354.
29. Rijal, S., Koirala, S., van der Stuyft, P. & Boelaert, M. (2006). The economic burden of visceral leishmaniasis for households in Nepal. Transactions of the Royal Society of Tropical Medicine and Hygiene, 100, 838-841.
30. Rijal, S., Uranw, S., Chappuis, F., Picado, A., Khanal, B., Paudel, I. S., Andersen, E. W., Meheus, F., Ostyn, B., Das, M. L., Davies, C. & Boelaert, M. (2010). Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Tropical Medicine and International Health, 15 (Suppl. 2), 21-28.
31. Robays, J., Bilengue, M. M., Stuyft, P. V. & Boelaert, M. (2004). The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo. Tropical Medicine and International Health, 9, 542-550.
32. Sarnoff, R., Desai, J., Desjeux, P., Mittal, A., Topno, R., Siddiqui, N. A., Pandey, A., Sur, D. & Das, P. (2010). The economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India. Tropical Medicine and International Health, 15 (Suppl. 2), 42-49.
33. Schaefer, K. U., Kurtzhals, J. A., Gachihi, G. S., Muller, A. S. & Kager, P. A. (1995). A prospective sero-epidemiological study of visceral leishmaniasis in Baringo district, Rift Valley province, Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 471-475.
34. Seifert, K., Matu, S., Perez-Victoria, F. J., Castanys, S., Gamarro, F. & Croft, S. L. (2003). Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). International Journal of Antimicrobial Agents, 22, 380-387.
35. Sharma, A. D., Bern, C., Varghese, B., Chowdhury, R., Haque, R., Ali, M., Amann, J., Ahluwalia, I. B., Wagatsuma, Y., Breiman, R. F., Maguire, J. H. & McFarland, D. A. (2006). The economic impact of visceral leishmaniasis on households in Bangladesh. Tropical Medicine and International Health, 11, 757-764.
36. Sharma, B. P., Maskay, N. M., Adhikari, S. R., Andrews, J. R., Joshi, A. B., Wijeyaratne, P. & Joshi, S. D. (2004). Socio-economic determinants of kala-azar in Nepal. Journal of the Nepal Health Research Council, 2, 35-42.
37. Shaw, A. P. (1989). Comparative analysis of the costs and benefits of alternative disease control strategies: vector control versus human case finding and treatment. Annales de la Société Belge de Médecine Tropicale, 69 (Suppl. 1), 237-253.
38. Shaw, A. P. & Cattand, P. (2001). Analytical tools for planning cost-effective surveillance in gambiense sleeping sickness. Médecine Tropicale, 61, 412-421.
39. Singh, S. P., Reddy, D. C. S., Rai, M. & Sundar, S. (2006). Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Tropical Medicine and International Health, 11, 899-905.
40. Singh, S. P., Picado, A., Boelaert, M., Gidwani, K., Andersen, E. W., Ostyn, B., Meheus, F., Rai, M., Chappuis, F., Davies, C. & Sundar, S. (2010a). The epidemiology of Leishmania donovani infection in high transmission foci in India. Tropical Medicine and International Health, 15 (Suppl. 2), 12-20.
41. Singh, V. P., Ranjan, A., Topno, R. K., Verma, R. B., Siddique, N. A., Ravidas, V. N., Kumar, N., Pandey, K. & Das, P. (2010b). Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India. American Journal of Tropical Medicine and Hygiene, 82, 9-11.
42. Stanghellini, A. & Josenando, T. (2001). The situation of sleeping sickness in Angola: a calamity. Tropical Medicine and International Health, 6, 330-334.
43. Sundar, S., More, D. K., Singh, M. K., Singh, V. P., Sharma, S., Makharia, A., Kumar, P. C. & Murray, H. W. (2000). Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clinical Infectious Diseases, 31, 1104-1107.
44. Sundar, S., Jha, T. K., Thakur, C. P., Engel, J., Sindermann, H., Fischer, C., Junge, K., Bryceson, A. & Berman, J. (2002). Oral miltefosine for Indian visceral leishmaniasis. New England Journal of Medicine, 347, 1739-1746.
45. Sundar, S., Arora, R., Singh, S. P., Boelaert, M. & Varghese, B. (2010a). Household cost-of-illness of visceral leishmaniasis in Bihar, India. Tropical Medicine and International Health, 15 (Suppl. 2), 50-54.
46. Sundar, S., Chakravarty, J., Agarwal, D., Rai, M. & Murray, H. W. (2010b). Single-dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine, 362, 504-512.
47. Thakur, C. P. (2000). Socioeconomic of visceral leishmaniasis in Bihar (India). Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 156-157.
48. Thakur, C. P., Kanyok, T. P., Pandey, A. K., Sinha, G. P., Zaniewski, A. E., Houlihan, H. H. & Olliaro, P. (2000). A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 429-431.
49. Trouiller, P., Torreele, E., Olliaro, P., White, N., Foster, S., Wirth, D. & Pecoul, B. (2001). Drugs for neglected diseases: a failure of the market and a public health failure? Tropical Medicine and International Health, 6, 945-951.
50. Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R. & Ford, N. (2002). Drug development for neglected diseases: a deficient market and a publichealth policy failure. Lancet, 359, 2188-2194.
51. Vanlerberghe, V., Diap, G., Guerin, P. J., Meheus, F., Gerstl, S., van der Stuyft, P. & Boelaert, M. (2007). Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. Tropical Medicine and International Health, 12, 274-283.
52. Veeken, H., Ritmeijer, K., Seaman, J. & Davidson, R. (2000). A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan. Tropical Medicine and International Health, 5, 312-317.
53. Welburn, S. C., Fèvre, E. M., Coleman, P. G., & Maudlin, I. (2004). Epidemiology of human African trypanosomiasis. In The Trypanosomiases, eds Maudlin, I., Holmes, P. H. & Miles, M. A. pp. 219-232. Wallingford, U. K.: CABI.
54. Zijlstra, E. E., ElHassan, A. M., Ismael, A. & Ghalib, H. W. (1994). Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. American Journal of Tropical Medicine and Hygiene, 51, 826-836.